The FDA has granted approval for Kites Tecartus (brexucabtagene autoleucel) for the treatment of adult patients (18 years and older) with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Tecartus is the first and only chimeric antigen receptor (CAR) T-cell therapy approved for adults (18 years and older) with ALL.
NEW YORK, Oct. 1, 2021 /PRNewswire/ --BrainStorm Cell Therapeutics Inc.
Stemtech invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference MIRAMAR, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Stemtech Corporation (Symbol: GNTW), a leading nutraceutical company and a pioneer in the field of stem cell nutrition, is pleased to announce that it has been invited to present at the Emerging Growth Conference on Wednesday, September 29, 2021. The Emerging Growth Conference is a live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Companys COO, John W.
A recent study shows real promise towards a bioartificial pancreas. This story is part one in anoccasionalseries on the currentprogression in Regenerative Medicine. In 1999, I definedregenerative medicine as thecollection of interventions that restore tonormal function tissues and organs that have beendamaged by disease, injured by trauma, or worn by time
The latest published report namely Global Stem Cell Manufacturing Market Size, Share, Growth, Industry Trends and Forecast to 2028 added by Data Bridge Market Research offers an insightful take on the historical data of the market and predictions for 2021 to 2028 time-period. The report provides an understanding of the global Stem Cell Manufacturing industry competitors, the sales channel, growth potential, potentially disruptive trends, industry product innovations and the value/volume of size, market segments, and market share of the best actors/products. Current market trends and dynamics are assessed which helps in mapping the track of the global market
In the month of September every year, we celebrate blood cancer awareness month. There are types of blood cancer which include hematologic cancers that start in the bone marrow, which is where blood is produced. Blood cancers happen when abnormal blood cells start growing and cannot be controlled, and later disrupting the function of the normal blood cells, which then fight off infection and produce new blood cells
Get instant alerts when news breaks on your stocks.
Forecasts by Type (Allogenic, Autologous), by Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-Culture), by Application (Therapeutic Application (Cancer, Cardiovascular, CNS, and Others), Non-Therapeutic Application) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Stem Cell Technology Companies AND COVID-19 Recovery Scenarios New York, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Stem Cell Technologies and Applications Market Report 2021-2031" - https://www.reportlinker.com/p06151326/?utm_source=GNW Global Stem Cell Technologies & Applications Market - our new study reveals trends, pipeline analysis, R&D activities and predicted revenues How will the global stem cell technologies and applications industry evolve during the forecast period from 2021-2031?
Introduction At present, in reproductive medicine, endometrial loss or insufficient endometrial thickness has become one of the main problems that affect the successful implantation and normal growth of embryos. Therapeutic methods used to promote endometrial regeneration at home and abroad include exogenous estrogen, low-dose aspirin, sildenafil citrate, pentoxifylline, vitamin E, L-arginine, cytokines, electroacupuncture, and biofeedback therapy
COLOGNE, Germany For older adults, aging bones get thinner, fracture more often, and become more susceptible to diseases like osteoporosis. Part of the reason for this is the decline in function of bone marrow stem cells, which are vital to bone integrity throughout a persons life.
Recent Comments